A mid-size pharmaceutical company unexpectedly obtained a marketed CNS drug and needed to understand the financial impact of various commercialization strategies. Due to the newly acquired drug being in an adjacent market to the sponsor’s flagship product, there was uncertainty regarding investing in commercialization or eliminating from their product mix. Given the volatility of the market and potential synergies between the two drugs, Kineticos was retained to develop a scenario-based forecast model, considering factors such as sales force sizing, advertising & promotional spend, pricing, and managed care acceptance.
For the full case study including example deliverables, click here: Commercial Strategy
Subscribe to the Kineticos Research Institute to receive weekly emails containing insightful content.